Joel Greenblatt's JNJ Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 239,366 shares of Johnson & Johnson (JNJ) worth $49.54 M, representing 0.18% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2014, adding 776,210 shares. Largest reduction occurred in Q2 2015, reducing 833,196 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +26,330 | Add 12.36% | 239,366 | $206.95 |
| Q3 2025 | +28,690 | Add 15.56% | 213,036 | $185.42 |
| Q2 2025 | +85,914 | Add 87.28% | 184,346 | $152.75 |
| Q1 2025 | -100,695 | Reduce 50.57% | 98,432 | $165.84 |
| Q4 2024 | -18,510 | Reduce 8.50% | 199,127 | $144.62 |
| Q3 2024 | -386 | Reduce 0.18% | 217,637 | $162.06 |
| Q2 2024 | +45,724 | Add 26.54% | 218,023 | $146.16 |
| Q1 2024 | +11,956 | Add 7.46% | 172,299 | $158.19 |
| Q4 2023 | +35,351 | Add 28.28% | 160,343 | $156.74 |
| Q3 2023 | +10,320 | Add 9.00% | 124,992 | $155.75 |
| Q2 2023 | -1,670 | Reduce 1.44% | 114,672 | $165.52 |
| Q1 2023 | +25,141 | Add 27.57% | 116,342 | $155.00 |
| Q4 2022 | -5,174 | Reduce 5.37% | 91,201 | $176.65 |
| Q3 2022 | +19,696 | Add 25.69% | 96,375 | $163.36 |
| Q2 2022 | -1,388 | Reduce 1.78% | 76,679 | $177.51 |
| Q1 2022 | -24,489 | Reduce 23.88% | 78,067 | $177.23 |
| Q4 2021 | -10,078 | Reduce 8.95% | 102,556 | $171.07 |
| Q3 2021 | +45,479 | Add 67.72% | 112,634 | $161.50 |
| Q2 2021 | +10,557 | Add 18.65% | 67,155 | $164.74 |
| Q1 2021 | -64,562 | Reduce 53.29% | 56,598 | $164.35 |
| Q4 2020 | -37,720 | Reduce 23.74% | 121,160 | $157.38 |
| Q3 2020 | -40,758 | Reduce 20.42% | 158,880 | $148.88 |
| Q2 2020 | +54,091 | Add 37.16% | 199,638 | $140.63 |
| Q1 2020 | -25,188 | Reduce 14.75% | 145,547 | $131.13 |
| Q4 2019 | -180,415 | Reduce 51.38% | 170,735 | $145.87 |
| Q3 2019 | +16,288 | Add 4.86% | 351,150 | $129.38 |
| Q2 2019 | +113,272 | Add 51.12% | 334,862 | $139.28 |
| Q1 2019 | -106,786 | Reduce 32.52% | 221,590 | $139.79 |
| Q4 2018 | -36,757 | Reduce 10.07% | 328,376 | $129.05 |
| Q3 2018 | -49,031 | Reduce 11.84% | 365,133 | $138.17 |
| Q2 2018 | +23,338 | Add 5.97% | 414,164 | $121.34 |
| Q1 2018 | +150,859 | Add 62.87% | 390,826 | $128.15 |
| Q4 2017 | +159,084 | Add 196.68% | 239,967 | $139.72 |
| Q3 2017 | +55,950 | Add 224.40% | 80,883 | $130.01 |
| Q2 2017 | -266,363 | Reduce 91.44% | 24,933 | $132.27 |
| Q1 2017 | -184,426 | Reduce 38.77% | 291,296 | $124.55 |
| Q4 2016 | +261,679 | Add 122.26% | 475,722 | $115.21 |
| Q3 2016 | +209,137 | Add 4262.88% | 214,043 | $118.13 |
| Q2 2016 | -237,137 | Reduce 97.97% | 4,906 | $121.28 |
| Q1 2016 | +202,457 | Add 511.44% | 242,043 | $108.20 |
| Q4 2015 | +39,586 | New Buy | 39,586 | $102.71 |
| Q2 2015 | -833,196 | Sold Out | 0 | $0.00 |
| Q1 2015 | +42,667 | Add 5.40% | 833,196 | $100.60 |
| Q4 2014 | +776,210 | Add 5420.84% | 790,529 | $104.57 |
| Q3 2014 | +14,319 | New Buy | 14,319 | $106.57 |
| Q2 2014 | -7,496 | Sold Out | 0 | $0.00 |
| Q1 2014 | +7,496 | New Buy | 7,496 | $98.19 |
| Q4 2013 | -32,599 | Sold Out | 0 | $0.00 |
| Q3 2013 | +32,599 | New Buy | 32,599 | $86.69 |
Joel Greenblatt's Johnson & Johnson Investment FAQs
Joel Greenblatt first purchased Johnson & Johnson (JNJ) in Q3 2013, acquiring 32,599 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Johnson & Johnson (JNJ) for 49 quarters since Q3 2013.
Joel Greenblatt's largest addition to Johnson & Johnson (JNJ) was in Q4 2014, adding 790,529 shares worth $82.67 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 239,366 shares of Johnson & Johnson (JNJ), valued at approximately $49.54 M.
As of the Q4 2025 filing, Johnson & Johnson (JNJ) represents approximately 0.18% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Johnson & Johnson (JNJ) was 833,196 shares, as reported at the end of Q1 2015.